Back
Kairos Pharma Stock Price Chart
Sponsored
KAPA
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
KAPA
Kairos Pharma
Last Price:
1.61
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and KAPA is experiencing slight selling pressure.
Kairos Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.69 | Sell |
20-day SMA: | 1.52 | Buy |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 1.59 | Buy |
20-day EMA: | 1.53 | Buy |
50-day EMA: | 1.21 | Buy |
200-day EMA: | 0.49 | Buy |
Kairos Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 49.3 | Sell |
Chaikin Money Flow: | -44456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.27 - 1.75) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
Kairos Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Kairos Pharma Stock
Is Kairos Pharma Stock a Buy?
- Kairos Pharma share price is 1.60 while KAPA 8-day simple moving average is 1.69, which is a Sell signal.
- The stock price of KAPA is 1.60 while Kairos Pharma 20-day SMA is 1.52, which makes it a Buy.
- Kairos Pharma 50-day simple moving average is 0.00 while KAPA share price is 1.60, making it a Buy technically.
- KAPA stock price is 1.60 and Kairos Pharma 200-day simple moving average is 0.00, creating a Buy signal.
KAPA Technical Analysis vs Fundamental Analysis
Sell
14
Kairos Pharma (KAPA)
is a Sell
Is Kairos Pharma a Buy or a Sell?
-
Kairos Pharma stock is rated a Sell
The current Kairos Pharma [KAPA] share price is $1.60. The Score for KAPA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
Kairos Pharma Stock Info
Market Cap:
20.55M
Price in USD:
1.60
Share Volume:
255.51K
Kairos Pharma 52-Week Range
52-Week High:
4.00
52-Week Low:
1.22
Sell
14
Kairos Pharma (KAPA)
is a Sell
Kairos Pharma Share Price Forecast
-
What is the Kairos Pharma stock price today?
The Kairos Pharma stock price is 1.60 USD today. -
Will KAPA stock go up or go down?
Kairos Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is Kairos Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kairos Pharma is overvalued.
Is Kairos Pharma Stock a Buy?
- Kairos Pharma share price is 1.60 while KAPA 8-day exponential moving average is 1.59, which is a Buy signal.
- The stock price of KAPA is 1.60 while Kairos Pharma 20-day EMA is 1.53, which makes it a Buy.
- Kairos Pharma 50-day exponential moving average is 1.21 while KAPA share price is 1.60, making it a Buy technically.
- KAPA stock price is 1.60 and Kairos Pharma 200-day simple moving average is 0.49, creating a Buy signal.
Fundamental Analysis of Kairos Pharma
Is Kairos Pharma a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.
Technical Analysis of Kairos Pharma
Should I short Kairos Pharma stock?
- KAPA Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Kairos Pharma is a Buy
- Kairos Pharma Relative Strength Index (RSI) is 49.3, which suggest Kairos Pharma is oversold
- The Bollinger Bands (25) for Kairos Pharma is (1.27 - 1.75), which suggest Kairos Pharma is a Buy
- The Bollinger Bands (100) for Kairos Pharma is ( - ), which suggest Kairos Pharma is a Buy
* Kairos Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.